Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia

NCT00233545 is registered in ClinicalTrials.gov with AB Foundation as lead sponsor.

NCT NCT00233545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00233545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia
Lead sponsor
AB Foundation
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2005
Completion date
September 30, 2007
Enrollment
80
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniasis